Fund
| Item | Value |
|---|---|
| Ticker (pseudo) | FBMH |
| CUSIP | Not applicable (hypothetical model portfolio) |
| Listing exchange | Not listed (hypothetical) |
| Underlying model | Book-to-Market Value factor (Healthcare only) |
| Placeholder expense ratio | 0.45% |
Loading the page
| Item | Value |
|---|---|
| Ticker (pseudo) | FBMH |
| CUSIP | Not applicable (hypothetical model portfolio) |
| Listing exchange | Not listed (hypothetical) |
| Underlying model | Book-to-Market Value factor (Healthcare only) |
| Placeholder expense ratio | 0.45% |
| Placeholder inception date |
| 2020-10-09 |
| Number of holdings (long leg) | 66 |
| Weighting | Cap-weighted |
| Rebalance frequency | Monthly |
| Holdings as of | November 2026 |
| # | Ticker | Company | Sector | Weight | Market Value | CUSIP |
|---|---|---|---|---|---|---|
| 1 | REGN | REGENERON PHARMACEUTICALS INC | Healthcare | 64.54% | $64,535,987 | HYP-REGN |
| 2 | BIO | BIO-RAD LABORATORIES INC | Healthcare | 6.53% | $6,534,558 | HYP-BIO |
| 3 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 1.36% | $1,361,440 | HYP-VIR |
| 4 | HRMY | HARMONY BIOSCIENCES HOLDINGS INC | Healthcare | 1.30% | $1,301,757 | HYP-HRMY |
| 5 | AZTA | AZENTA INC | Healthcare | 1.26% | $1,260,175 | HYP-AZTA |
| 6 | AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | 1.25% | $1,245,877 | HYP-AGIO |
| 7 | INSP | INSPIRE MEDICAL SYSTEMS INC | Healthcare | 1.15% | $1,150,121 | HYP-INSP |
| 8 | SRPT | SAREPTA THERAPEUTICS INC | Healthcare | 1.13% | $1,125,985 | HYP-SRPT |
| 9 | KLRA | KAILERA THERAPEUTICS INC | Healthcare | 1.13% | $1,125,002 | HYP-KLRA |
| 10 | PCRX | PACIRA BIOSCIENCES INC | Healthcare | 0.96% | $958,806 | HYP-PCRX |
| 11 | KRSA | KORSANA BIOSCIENCES INC | Healthcare | 0.93% | $934,277 | HYP-KRSA |
| 12 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 0.93% | $931,522 | HYP-GPCR |
| 13 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 0.90% | $895,515 | HYP-TYRA |
| 14 | DMRA | DAMORA THERAPEUTICS INC | Healthcare | 0.90% | $895,253 | HYP-DMRA |
| 15 | INVA | INNOVIVA INC | Healthcare | 0.88% | $884,365 | HYP-INVA |
| 16 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 0.83% | $834,126 | HYP-NKTR |
| 17 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 0.72% | $718,367 | HYP-MLTX |
| 18 | JBIO | JADE BIOSCIENCES INC | Healthcare | 0.66% | $661,962 | HYP-JBIO |
| 19 | BBNX | BETA BIONICS INC | Healthcare | 0.59% | $588,702 | HYP-BBNX |
| 20 | RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | 0.56% | $564,239 | HYP-RIGL |
| 21 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 0.52% | $521,739 | HYP-GLUE |
| 22 | SLDB | SOLID BIOSCIENCES INC | Healthcare | 0.51% | $512,426 | HYP-SLDB |
| 23 | VREX | VAREX IMAGING CORP | Healthcare | 0.50% | $504,490 | HYP-VREX |
| 24 | AURA | AURA BIOSCIENCES INC | Healthcare | 0.49% | $485,339 | HYP-AURA |
| 25 | ATTO | ATTOVIA THERAPEUTICS INC | Healthcare | 0.47% | $473,992 | HYP-ATTO |
| 26 | JANX | JANUX THERAPEUTICS INC | Healthcare | 0.46% | $461,268 | HYP-JANX |
| 27 | FLGT | FULGENT GENETICS INC | Healthcare | 0.46% | $455,366 | HYP-FLGT |
| 28 | SGMT | SAGIMET BIOSCIENCES INC | Healthcare | 0.45% | $445,593 | HYP-SGMT |
| 29 | FDMT | 4D MOLECULAR THERAPEUTICS INC | Healthcare | 0.44% | $438,969 | HYP-FDMT |
| 30 | DNA | GINKGO BIOWORKS HOLDINGS INC | Healthcare | 0.43% | $434,968 | HYP-DNA |
| 31 | OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | 0.43% | $432,082 | HYP-OLMA |
| 32 | CAPR | CAPRICOR THERAPEUTICS INC | Healthcare | 0.39% | $390,501 | HYP-CAPR |
| 33 | IMMX | IMMIX BIOPHARMA INC | Healthcare | 0.38% | $378,630 | HYP-IMMX |
| 34 | NGNE | NEUROGENE INC | Healthcare | 0.32% | $324,521 | HYP-NGNE |
| 35 | ARVN | ARVINAS INC | Healthcare | 0.30% | $295,073 | HYP-ARVN |
| 36 | AVTX | AVALO THERAPEUTICS INC | Healthcare | 0.29% | $291,990 | HYP-AVTX |
| 37 | MOBI | MOBIA MEDICAL INC | Healthcare | 0.29% | $290,941 | HYP-MOBI |
| 38 | PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | 0.28% | $277,168 | HYP-PRTA |
| 39 | TECX | TECTONIC THERAPEUTIC INC | Healthcare | 0.28% | $275,266 | HYP-TECX |
| 40 | ASMB | ASSEMBLY BIOSCIENCES INC | Healthcare | 0.27% | $269,494 | HYP-ASMB |
| 41 | LYEL | LYELL IMMUNOPHARMA INC | Healthcare | 0.25% | $252,179 | HYP-LYEL |
| 42 | CTNM | CONTINEUM THERAPEUTICS INC | Healthcare | 0.25% | $251,851 | HYP-CTNM |
| 43 | PEPG | PEPGEN INC | Healthcare | 0.23% | $228,962 | HYP-PEPG |
| 44 | EIKN | EIKON THERAPEUTICS INC | Healthcare | 0.21% | $214,598 | HYP-EIKN |
| 45 | BNTC | BENITEC BIOPHARMA INC | Healthcare | 0.21% | $207,974 | HYP-BNTC |
| 46 | EVMN | EVOMMUNE INC | Healthcare | 0.19% | $190,922 | HYP-EVMN |
| 47 | OFIX | ORTHOFIX MEDICAL INC | Healthcare | 0.19% | $185,544 | HYP-OFIX |
| 48 | QTTB | Q32 BIO INC | Healthcare | 0.17% | $173,082 | HYP-QTTB |
| 49 | BIOA | BIOAGE LABS INC | Healthcare | 0.17% | $170,328 | HYP-BIOA |
| 50 | ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | 0.16% | $159,571 | HYP-ARCT |
| 51 | UTMD | UTAH MEDICAL PRODUCTS INC | Healthcare | 0.15% | $153,734 | HYP-UTMD |
| 52 | RXST | RXSIGHT INC | Healthcare | 0.15% | $147,963 | HYP-RXST |
| 53 | AMWL | AMERICAN WELL CORP | Healthcare | 0.14% | $135,895 | HYP-AMWL |
| 54 | TRDA | ENTRADA THERAPEUTICS INC | Healthcare | 0.13% | $132,747 | HYP-TRDA |
| 55 | KROS | KEROS THERAPEUTICS INC | Healthcare | 0.13% | $129,730 | HYP-KROS |
| 56 | KRRO | KORRO BIO INC | Healthcare | 0.13% | $128,811 | HYP-KRRO |
| 57 | ANIK | ANIKA THERAPEUTICS INC | Healthcare | 0.12% | $121,335 | HYP-ANIK |
| 58 | INGN | INOGEN INC | Healthcare | 0.10% | $95,822 | HYP-INGN |
| 59 | RNA | ATRIUM THERAPEUTICS INC | Healthcare | 0.08% | $84,147 | HYP-RNA |
| 60 | SPRB | SPRUCE BIOSCIENCES INC | Healthcare | 0.08% | $80,868 | HYP-SPRB |
| 61 | IMUX | IMMUNIC INC | Healthcare | 0.07% | $69,718 | HYP-IMUX |
| 62 | RLYB | RALLYBIO CORP | Healthcare | 0.06% | $55,289 | HYP-RLYB |
| 63 | VTVT | VTV THERAPEUTICS INC | Healthcare | 0.05% | $54,437 | HYP-VTVT |
| 64 | XLO | XILIO THERAPEUTICS INC | Healthcare | 0.04% | $38,171 | HYP-XLO |
| 65 | YARW | YARROW BIOSCIENCE INC | Healthcare | 0.03% | $34,367 | HYP-YARW |
| 66 | ELOX | ELOXX PHARMACEUTICALS INC | Healthcare | 0.03% | $34,105 | HYP-ELOX |
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.